← Open Payments lookup

PAUL BOYD: Open Payments

NPI 1699250886 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$638 in 31 payments from 15 companies in 2025. Trend: 2023 $891 · 2024 $913 · 2025 $638

Food & beverage: $638
CompanyPaymentsAmount
Gilead Sciences, Inc.8$141
Amgen Inc.4$84
Lilly USA, LLC3$60
Janssen Pharmaceuticals, Inc2$59
Boehringer Ingelheim Pharmaceuticals, Inc.2$52
AstraZeneca Pharmaceuticals LP3$50
Phathom Pharmaceuticals, Inc.1$31
Astellas Pharma US Inc1$27
Merck Sharp & Dohme LLC1$24
Novo Nordisk Inc1$21

Products named: OTEZLA, SPRAVATO, MOUNJARO, BREZTRI, VOQUEZNA, Veozah, PIFELTRO, REPATHA.

Industry payments across CA — which companies pay providers there.